论文部分内容阅读
目的:探讨正常范围同型半胱氨酸不同水平与复发性脑梗死的相关性。方法:收治急性缺血性脑卒中患者100例为试验组,分不同亚组,收治非急性脑血管病患者150例为对照组,比较初发和复发患者的血浆Hcy水平,不同类型脑卒中患者的血浆Hcy水平。结果:试验组(血栓组、栓塞组和腔梗组)的血浆Hcy水平高于对照组(P<0.05)。初发组血Hcy水平低于复发组(P<0.05)。结论:正常范围内,高水平同型半胱氨酸仍是复发性脑梗死的独立危险因素。
Objective: To investigate the correlation between different levels of homocysteine in normal range and recurrent cerebral infarction. Methods: 100 patients with acute ischemic stroke admitted to the trial group, sub-subgroups of 150 cases of non-acute cerebrovascular disease were treated as control group, comparing the plasma Hcy levels in patients with initial and recurrent disease, different types of stroke patients Plasma Hcy levels. Results: Plasma Hcy levels in the experimental group (thrombosis group, embolism group and luminal group) were higher than those in the control group (P <0.05). The level of Hcy in the primary group was lower than that in the recurrent group (P <0.05). Conclusion: Homocysteine is still an independent risk factor for recurrent cerebral infarction in the normal range.